CWA Asset Management Group’s Core Laboratories CLB Stock Holding History

CWA Asset Management Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4M	Buy	1,755,085 +14,084	+0.8%	+$201K	0.62%	30
2026 Q1	$29.2M	Buy	1,741,001 +1,118,548	+180%	+$20M	0.99%	21
2025 Q4	$9.98M	Buy	+622,453	New	+$9.26M	0.36%	56
2023 Q1	–	Sell	-129,772	Closed	-$2.63M	–	328
2022 Q4	$2.63M	Buy	+129,772	New	+$2.52M	0.21%	98

Other funds holding CLB

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

CMA

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

CWA Asset Management Group's CLB Position: Q2 2026 in Review

CWA Asset Management Group increased its Core Laboratories (CLB) stake by 0.81% in Q2 2026, buying an estimated $201K and bringing the position to 1,755,085 shares worth $20.4M. The position accounts for 0.62% of the portfolio, ranked #30.

CWA Asset Management Group first reported a position in CLB in Q4 2022 and has held it in 4 quarters since. The position peaked at $29.2M in Q1 2026. 11 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

CWA Asset Management Group held 1,755,085 shares of Core Laboratories worth $20.4M as of Q2 2026.
CWA Asset Management Group bought 14,084 Core Laboratories shares in Q2 2026, an estimated $201K.
Core Laboratories made up 0.62% of CWA Asset Management Group's portfolio in Q2 2026, its #30 holding.
CWA Asset Management Group first reported a position in Core Laboratories in Q4 2022 and has held it in 4 quarters since.
CWA Asset Management Group's Core Laboratories position peaked at $29.2M in Q1 2026.
11 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.